The magical smell and taste: Can coffee be good to patients with cardiometabolic disease?

Abstract

Coffee is a beverage consumed globally. Although few studies have indicated adverse effects, it is typically a beneficial health-promoting agent in a range of diseases, including depression, diabetes, cardiovascular disease, and obesity. Coffee is rich in caffeine, antioxidants, and phenolic compounds, which can modulate the composition of the gut microbiota and mitigate both inflammation and oxidative stress, common features of the burden of lifestyle diseases. This review will discuss the possible benefits of coffee on complications present in patients with diabetes, cardiovascular disease and chronic kidney disease, outwith the social and emotional benefits attributed to caffeine consumption.

Keywords:

• burden of lifestyle diseases
• coffee
• coffee phytochemicals structure
• gut microbiota
• inflammation
• oxidative stress

Acknowledgements

The authors would like to thank the Coordination for the Improvement of Higher Education Personnel (CAPES), the National Research Council (CNPq) and the Rio de Janeiro State Research Support Foundation (FAPERJ) for their financial support. There is no conflict of interest to declare.

Disclosure statement

No potential conflict of interest was reported by the authors.

Author contributions

All authors wrote sections of the first draft, thoroughly edited the manuscript, and approved the final draft.

Additional information

Funding

Conselho Nacional de Pesquisa (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), and Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) support Denise Mafra research.